Aguanta, Beverly C.
HRN: 12-30-48 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2023
AZITHROMYCIN 500MG TABLET (TAB)
01/10/2023
01/14/2023
PO
500mg
OD
CAP MR
Waiting Final Action
01/10/2023
CEFTRIAXONE 1G (VIAL)
01/10/2023
01/17/2023
IV
2g
OD
CAP MR
Waiting Final Action
01/21/2023
LEVOFLOXACIN 500MG (TAB)
01/21/2023
01/27/2023
PO
500mg Tab
OD
Pneumonja
Waiting Final Action